ArticleACR open rheumatology2026
Cognitive Screening and Neuropsychological Evaluation in Children and Young Adults With Childhood-Onset Systemic Lupus Erythematosus: A Survey of Rheumatologists.
Article in ACR open rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveTo assess current beliefs and clinical practice in rheumatology around cognitive screening and neuropsychological evaluation in youth with childhood-onset systemic lupus erythematosus (cSLE).
methodsA cross-sectional survey study was conducted among rheumatologists and trainees of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) who care for individuals with cSLE <21 years old. This survey assessed provider knowledge, beliefs, and practices around cognitive screening and neuropsychological evaluation. The presence and absence of barriers to screening (n = 11) and evaluation (n = 8) were also assessed.
resultsOf 443 eligible CARRA members, 109 (25%) completed the survey. The majority of respondents thought that cognitive dysfunction was common in cSLE (94%), had long-term effects on a patient's health (100%), and that the medical literature supported routine screening for cognitive dysfunction (93%). However, only 61% routinely asked about or screened for cognitive concerns during clinic visits, and only 28% felt able to adequately address cognitive concerns. Barriers to performing cognitive screening included uncertainty with administration, interpreting results, billing, and the time available to complete it. Routine neuropsychological evaluation was rare (8%), and more than half (54%) reported that their patients were rarely or never evaluated. Barriers to neuropsychological evaluation included difficulty accessing these services and the time required for the assessment.
conclusionRheumatologists believe cognitive screening and neuropsychological evaluation are important components of care for youth with cSLE but face multiple barriers related to limited training, time, and access to appropriate services. Future work addressing these barriers will support these providers and improve care for patients with cSLE.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.